Skip to content

Evaluation of Efficacy and Safety of Majoon e Ushba orally and locally paste in the management of fungal infection.

Evaluation of efficacy and safety of Majoon e Ushba orally and Zimad (a herbomineral unani formulation) topically in the management of Quba (Tinea corporis) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093922
Enrollment
44
Registered
2025-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Zimad contain following ingredients: 1.Suhaga (Borax)3gm 2.Murdar sang (Litharge)3gm 3.Kath safaid (Acacia catechu)3gm 4.Tukhm panwad (Cassiatora)3gm 5.Gandhak (Sulpher)3gm 6.Raskapoor

Sponsors

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Bhopal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinically diagnosed and potassium hydroxide test (KOH) 2.Confirmed cases of dermatophytosis 3.Subjects who have agreed to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1.Patients suffering from concomitant diseases like psoriasis and eczema. 2.Patients suffering from severe systemic and metabolic diseases like diabetes mellitus, hepato renal dysfunctions etc. 3.Pregnant and lactating women. 4.Patients who have received any topical antifungal therapy within last 2 weeks or oral antifungal therapy in the previous 4 weeks.

Design outcomes

Primary

MeasureTime frame
1. DSS (Dermatophytosis severity score) 2. Mycological cure (KOH test)Timepoint: On Days 1, 14 and 35

Secondary

MeasureTime frame
DLQI score (Dermatologically life quality index)Timepoint: 1st day and 35 day

Countries

India

Contacts

Public ContactAbdul Rehman Ali

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Bhopal

mgauri52@gmail.com9981817255

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026